Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells
James A. Bonner, Donald J. Buchsbaum, Buck E. Rogers, William E. Grizzle, Hoa Q. Trummell, David T. Curiel, John B. Fiveash, Roger Ove, Kevin P. Raisch
Dive into the research topics of 'Adenoviral vector-mediated augmentation of epidermal growth factor receptor (EGFr) enhances the radiosensitization properties of anti-EGFr treatment in prostate cancer cells'. Together they form a unique fingerprint.